Innate immunity in inflammatory bowel disease: a disease hypothesis

Crohn's disease arises from a defective interaction between the highly concentrated mass of bacteria in the gastrointestinal tract and the underlying tissues. It has generally been believed to result from an excessively exuberant inflammatory response or from 'autoimmunity'. Recent ev...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of pathology 2008-01, Vol.214 (2), p.260-266
Hauptverfasser: Marks, DJB, Segal, AW
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 266
container_issue 2
container_start_page 260
container_title The Journal of pathology
container_volume 214
creator Marks, DJB
Segal, AW
description Crohn's disease arises from a defective interaction between the highly concentrated mass of bacteria in the gastrointestinal tract and the underlying tissues. It has generally been believed to result from an excessively exuberant inflammatory response or from 'autoimmunity'. Recent evidence has emerged that the problem is instead a failure of the way in which the body responds to the penetration of bacteria and other bowel contents through the intestinal mucosal barrier. Rather than Crohn's disease being caused by excessive inflammation, the primary mechanism is actually that of an immunodeficiency. Failure of inflammatory mediator production leads to insufficient recruitment of neutrophils, resulting in inadequate removal of bacteria and other debris. This impairment of acute inflammation can be compensated in some circumstances by signalling through NOD2. If not cleared, the foreign material in the bowel wall is taken up within macrophages, eliciting a granulomatous reaction and the local and systemic sequelae so characteristic of Crohn's disease. Copyright © 2007 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
doi_str_mv 10.1002/path.2291
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2635948</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70190560</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5411-818b6242b24eb9fad59ec972bb922f619c4d1fd6212d9df6ccbd5dfb688cfd923</originalsourceid><addsrcrecordid>eNp1kE1v1DAQhq0KRJfCoX-g5ITEIa3HiZ2YQ6XVin7ACiq1VY-WP7tuk3ixs5T8e7LKUuCAZGkszTPPjF6EDgEfA8bkZC371TEhHPbQDDBnOa85e4FmY4_kRQnVPnqd0gPGmHNKX6F9qIFBVVYztLjsOtnbzLftpvP9kPlufK6RbSv7EIdMhSfbZMYnK5P9mMnf32w1rEO_ssmnN-ilk02yb3f1AN2efbpZXOTLb-eXi_ky17QEyGuoFSMlUaS0ijtpKLeaV0QpTohjwHVpwBlGgBhuHNNaGWqcYnWtneGkOECnk3e9Ua012nZ9lI1YR9_KOIggvfi30_mVuA8_BGEF5WU9Ct7vBDF839jUi9YnbZtGdjZskqgwcEwZHsEPE6hjSCla97wEsNhGLraRi23kI3v091V_yF3GI3AyAU--scP_TeJqfnOxU-bThE-9_fk8IeOjYFVRUXH39Vwsr_iXz9fVmViO_LuJdzIIeR99ErfXBEOBcV0STqH4BccwpkY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70190560</pqid></control><display><type>article</type><title>Innate immunity in inflammatory bowel disease: a disease hypothesis</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Marks, DJB ; Segal, AW</creator><creatorcontrib>Marks, DJB ; Segal, AW</creatorcontrib><description>Crohn's disease arises from a defective interaction between the highly concentrated mass of bacteria in the gastrointestinal tract and the underlying tissues. It has generally been believed to result from an excessively exuberant inflammatory response or from 'autoimmunity'. Recent evidence has emerged that the problem is instead a failure of the way in which the body responds to the penetration of bacteria and other bowel contents through the intestinal mucosal barrier. Rather than Crohn's disease being caused by excessive inflammation, the primary mechanism is actually that of an immunodeficiency. Failure of inflammatory mediator production leads to insufficient recruitment of neutrophils, resulting in inadequate removal of bacteria and other debris. This impairment of acute inflammation can be compensated in some circumstances by signalling through NOD2. If not cleared, the foreign material in the bowel wall is taken up within macrophages, eliciting a granulomatous reaction and the local and systemic sequelae so characteristic of Crohn's disease. Copyright © 2007 Pathological Society of Great Britain and Ireland. Published by John Wiley &amp; Sons, Ltd.</description><identifier>ISSN: 0022-3417</identifier><identifier>EISSN: 1096-9896</identifier><identifier>DOI: 10.1002/path.2291</identifier><identifier>PMID: 18161747</identifier><language>eng</language><publisher>Chichester, UK: John Wiley &amp; Sons, Ltd</publisher><subject>Acute Disease ; bowel ; Crohn Disease - drug therapy ; Crohn Disease - genetics ; Crohn Disease - immunology ; Crohn's ; cytokine ; Gastrointestinal Agents - therapeutic use ; Genetic Predisposition to Disease ; Humans ; Immunity, Innate ; Invited Review ; macrophage ; neutrophil ; Neutrophils - immunology ; Nod2 Signaling Adaptor Protein - genetics ; Nod2 Signaling Adaptor Protein - physiology</subject><ispartof>The Journal of pathology, 2008-01, Vol.214 (2), p.260-266</ispartof><rights>Copyright © 2007 Pathological Society of Great Britain and Ireland. Published by John Wiley &amp; Sons, Ltd.</rights><rights>2007 Pathological Society of Great Britain and Ireland</rights><rights>Copyright © 2007 Pathological Society of Great Britain and Ireland. Published by John Wiley &amp; Sons, Ltd. 2007</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5411-818b6242b24eb9fad59ec972bb922f619c4d1fd6212d9df6ccbd5dfb688cfd923</citedby><cites>FETCH-LOGICAL-c5411-818b6242b24eb9fad59ec972bb922f619c4d1fd6212d9df6ccbd5dfb688cfd923</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fpath.2291$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fpath.2291$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,777,781,882,1412,27905,27906,45555,45556</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18161747$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Marks, DJB</creatorcontrib><creatorcontrib>Segal, AW</creatorcontrib><title>Innate immunity in inflammatory bowel disease: a disease hypothesis</title><title>The Journal of pathology</title><addtitle>J. Pathol</addtitle><description>Crohn's disease arises from a defective interaction between the highly concentrated mass of bacteria in the gastrointestinal tract and the underlying tissues. It has generally been believed to result from an excessively exuberant inflammatory response or from 'autoimmunity'. Recent evidence has emerged that the problem is instead a failure of the way in which the body responds to the penetration of bacteria and other bowel contents through the intestinal mucosal barrier. Rather than Crohn's disease being caused by excessive inflammation, the primary mechanism is actually that of an immunodeficiency. Failure of inflammatory mediator production leads to insufficient recruitment of neutrophils, resulting in inadequate removal of bacteria and other debris. This impairment of acute inflammation can be compensated in some circumstances by signalling through NOD2. If not cleared, the foreign material in the bowel wall is taken up within macrophages, eliciting a granulomatous reaction and the local and systemic sequelae so characteristic of Crohn's disease. Copyright © 2007 Pathological Society of Great Britain and Ireland. Published by John Wiley &amp; Sons, Ltd.</description><subject>Acute Disease</subject><subject>bowel</subject><subject>Crohn Disease - drug therapy</subject><subject>Crohn Disease - genetics</subject><subject>Crohn Disease - immunology</subject><subject>Crohn's</subject><subject>cytokine</subject><subject>Gastrointestinal Agents - therapeutic use</subject><subject>Genetic Predisposition to Disease</subject><subject>Humans</subject><subject>Immunity, Innate</subject><subject>Invited Review</subject><subject>macrophage</subject><subject>neutrophil</subject><subject>Neutrophils - immunology</subject><subject>Nod2 Signaling Adaptor Protein - genetics</subject><subject>Nod2 Signaling Adaptor Protein - physiology</subject><issn>0022-3417</issn><issn>1096-9896</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kE1v1DAQhq0KRJfCoX-g5ITEIa3HiZ2YQ6XVin7ACiq1VY-WP7tuk3ixs5T8e7LKUuCAZGkszTPPjF6EDgEfA8bkZC371TEhHPbQDDBnOa85e4FmY4_kRQnVPnqd0gPGmHNKX6F9qIFBVVYztLjsOtnbzLftpvP9kPlufK6RbSv7EIdMhSfbZMYnK5P9mMnf32w1rEO_ssmnN-ilk02yb3f1AN2efbpZXOTLb-eXi_ky17QEyGuoFSMlUaS0ijtpKLeaV0QpTohjwHVpwBlGgBhuHNNaGWqcYnWtneGkOECnk3e9Ua012nZ9lI1YR9_KOIggvfi30_mVuA8_BGEF5WU9Ct7vBDF839jUi9YnbZtGdjZskqgwcEwZHsEPE6hjSCla97wEsNhGLraRi23kI3v091V_yF3GI3AyAU--scP_TeJqfnOxU-bThE-9_fk8IeOjYFVRUXH39Vwsr_iXz9fVmViO_LuJdzIIeR99ErfXBEOBcV0STqH4BccwpkY</recordid><startdate>200801</startdate><enddate>200801</enddate><creator>Marks, DJB</creator><creator>Segal, AW</creator><general>John Wiley &amp; Sons, Ltd</general><scope>FBQ</scope><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>200801</creationdate><title>Innate immunity in inflammatory bowel disease: a disease hypothesis</title><author>Marks, DJB ; Segal, AW</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5411-818b6242b24eb9fad59ec972bb922f619c4d1fd6212d9df6ccbd5dfb688cfd923</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Acute Disease</topic><topic>bowel</topic><topic>Crohn Disease - drug therapy</topic><topic>Crohn Disease - genetics</topic><topic>Crohn Disease - immunology</topic><topic>Crohn's</topic><topic>cytokine</topic><topic>Gastrointestinal Agents - therapeutic use</topic><topic>Genetic Predisposition to Disease</topic><topic>Humans</topic><topic>Immunity, Innate</topic><topic>Invited Review</topic><topic>macrophage</topic><topic>neutrophil</topic><topic>Neutrophils - immunology</topic><topic>Nod2 Signaling Adaptor Protein - genetics</topic><topic>Nod2 Signaling Adaptor Protein - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Marks, DJB</creatorcontrib><creatorcontrib>Segal, AW</creatorcontrib><collection>AGRIS</collection><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Journal of pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Marks, DJB</au><au>Segal, AW</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Innate immunity in inflammatory bowel disease: a disease hypothesis</atitle><jtitle>The Journal of pathology</jtitle><addtitle>J. Pathol</addtitle><date>2008-01</date><risdate>2008</risdate><volume>214</volume><issue>2</issue><spage>260</spage><epage>266</epage><pages>260-266</pages><issn>0022-3417</issn><eissn>1096-9896</eissn><abstract>Crohn's disease arises from a defective interaction between the highly concentrated mass of bacteria in the gastrointestinal tract and the underlying tissues. It has generally been believed to result from an excessively exuberant inflammatory response or from 'autoimmunity'. Recent evidence has emerged that the problem is instead a failure of the way in which the body responds to the penetration of bacteria and other bowel contents through the intestinal mucosal barrier. Rather than Crohn's disease being caused by excessive inflammation, the primary mechanism is actually that of an immunodeficiency. Failure of inflammatory mediator production leads to insufficient recruitment of neutrophils, resulting in inadequate removal of bacteria and other debris. This impairment of acute inflammation can be compensated in some circumstances by signalling through NOD2. If not cleared, the foreign material in the bowel wall is taken up within macrophages, eliciting a granulomatous reaction and the local and systemic sequelae so characteristic of Crohn's disease. Copyright © 2007 Pathological Society of Great Britain and Ireland. Published by John Wiley &amp; Sons, Ltd.</abstract><cop>Chichester, UK</cop><pub>John Wiley &amp; Sons, Ltd</pub><pmid>18161747</pmid><doi>10.1002/path.2291</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-3417
ispartof The Journal of pathology, 2008-01, Vol.214 (2), p.260-266
issn 0022-3417
1096-9896
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2635948
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Acute Disease
bowel
Crohn Disease - drug therapy
Crohn Disease - genetics
Crohn Disease - immunology
Crohn's
cytokine
Gastrointestinal Agents - therapeutic use
Genetic Predisposition to Disease
Humans
Immunity, Innate
Invited Review
macrophage
neutrophil
Neutrophils - immunology
Nod2 Signaling Adaptor Protein - genetics
Nod2 Signaling Adaptor Protein - physiology
title Innate immunity in inflammatory bowel disease: a disease hypothesis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T06%3A36%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Innate%20immunity%20in%20inflammatory%20bowel%20disease:%20a%20disease%20hypothesis&rft.jtitle=The%20Journal%20of%20pathology&rft.au=Marks,%20DJB&rft.date=2008-01&rft.volume=214&rft.issue=2&rft.spage=260&rft.epage=266&rft.pages=260-266&rft.issn=0022-3417&rft.eissn=1096-9896&rft_id=info:doi/10.1002/path.2291&rft_dat=%3Cproquest_pubme%3E70190560%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70190560&rft_id=info:pmid/18161747&rfr_iscdi=true